Biomedisys is familiar with Food and Drug Administration (FDA) and International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) guidelines.
We have the ability to write and edit materials and analyze data in many medical arenas including:
- Biologics and therapeutic agents (including small molecules)
- Biotechnology
- Cardiology
- Gastroenterology
- Hematology/oncology
- Infectious diseases
- Internal medicine
- Medical devices
- Musculoskeletal diseases
- Neurosurgery (brain and spine)
- Ophthalmology
- Orthopedics
- Otolaryngology
- Pharmaceuticals
- Surgery (general and trauma)
- Obstetrics/gynecology and women’s health
- Public health, health administration, and insurance/managed care